http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106344575-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-439
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-22
filingDate 2016-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2019-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2019-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-106344575-B
titleOfInvention Application of alkaloid compounds in the preparation of drugs for the treatment of viral diseases
abstract The invention belongs to the technical field of medicine, and provides an application of an alkaloid compound in preparing a medicine for treating viral diseases. The alkaloid compounds are specifically Ussuriidine and Ussuriridone, which can be prepared by chemical synthesis or obtained by separation and purification from natural products. Experiments have shown that alkaloid compounds have inhibitory effects on cytopathies induced by enterovirus and herpes simplex virus, and can improve the survival rate of virus-infected cells, inhibit virus replication, improve the survival rate of virus-infected animals, and prolong the life of infected animals. Survival time, relieve symptoms caused by viral infection. Therefore, it can be applied to the preparation of medicines for treating viral diseases. The treatment of the viral disease includes the alkaloid compound, and a pharmaceutically acceptable carrier; the clinically acceptable oral dosage form, injection dosage form or topical dosage form for the treatment of the viral disease.
priorityDate 2016-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507729
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID138948
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID37542
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422710107
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1220758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422710146
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9598
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54608622
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1220758
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10298
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID12066
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398513
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID2725057
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555458
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11146
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID138948
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9534
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID2725057
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1049
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9534
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5905
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9598
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID12066
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10298
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553275
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408196011
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54602150

Total number of triples: 44.